
Canadian medtech company FluidAI said the FDA has granted 510(k) clearance for Origin, an inline sensing system that provides bedside monitoring of surgical effluent for patients in a post-operative setting.
Origin can work as a standalone device but it's planned to be integrated with FluidAI’s Stream Care. The device has been designed to connect to standard surgical drains and continuously provide care teams with real-time pH data visualization at the bedside.
Backed by strategic collaborations with global healthcare providers, government agencies, and leading research consortiums, the company said it is actively expanding the reach of its solutions across North America, Europe, and the Middle East with this clearance.






















